Search Medical Condition
Please enter condition
Please choose location

Mood Disorders Clinical Trials

A listing of Mood Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (234) clinical trials

This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.

Phase N/A

This study will evaluate rapastinel as alternate treatment for depression in patients with Major Depressive Disorder.

Phase

The purpose of this study is to evaluate the efficacy of vortioxetine treatment period in the prevention of relapse in participants with major depressive disorder (MDD).

Phase

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MUTLICENTER STUDY OF RAPASTINEL AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER

Phase

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MUTLICENTER STUDY OF RAPASTINEL AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER

Phase

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Phase N/A

Do you have a child with ADHD who is unable to control his or her anger? Being a parent of a child with ADHD can be challenging. And it can be even harder when the child has sudden outbursts of angry, aggressive behavior. If you or someone you know has ...

Phase

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Phase N/A

Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder

Participants will be randomized to receive double-blind suvorexant or placebo for one week, after which all participants will receive open treatment with suvorexant for three months.

Phase

Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Phase